Similar articles

• Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.

  Lynch G, Currie V, Kemeny N. Lynch G, et al. Cancer Clin Trials. 1981 Fall;4(3):281-3. Cancer Clin Trials. 1981. PMID: 6974612
• Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.

  Lynch GR, Gralla RJ, Kelsen DP, Casper ES, Stoopler MB, Golbey RB. Lynch GR, et al. Cancer Clin Trials. 1981 Fall;4(3):273-6. Cancer Clin Trials. 1981. PMID: 6974611
• Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.

  Carroll DS, Kemeny N, Lynch G, Wookcock T. Carroll DS, et al. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1149-50. Cancer Treat Rep. 1980. PMID: 6893951 No abstract available.
• Antimetastatic drugs: function and value.

  Hellmann K. Hellmann K. Prog Clin Biol Res. 1986;212:1-16. Prog Clin Biol Res. 1986. PMID: 3086890 Review. No abstract available.
• Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.

  Baker DE. Baker DE. Rev Gastroenterol Disord. 2003 Winter;3(1):31-8. Rev Gastroenterol Disord. 2003. PMID: 12684591 Review.